United States · FDA National Drug Code directory
ASPRUZYO SPRINKLE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 47335-625_2cd273e4-313f-3562-e063-6394a90ac135
- Product NDC
- 47335-625
- Form
- GRANULE
- Composition / generic term
- Ranolazine
- Labeler
- SUN PHARMACEUTICAL INDUSTRIES, INC.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20220228
- Source listing expiry
- 20261231
Source-listed ingredients
- RANOLAZINE — 1000 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 GRANULE in 1 PACKET (47335-625-11) · 47335-625-11
- 30 GRANULE in 1 CARTON (47335-625-30) · 47335-625-30
- 60 GRANULE in 1 CARTON (47335-625-60) · 47335-625-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →